What is NAD+?
NAD+ (Nicotinamide Adenine Dinucleotide, oxidized form) is a fundamental coenzyme found in every living cell, serving as a critical cofactor in hundreds of metabolic reactions and energy-producing pathways. Often described as the "energy currency" of the cell, NAD+ is central to cellular respiration, ATP production, and the regulation of aging pathways. While NAD+ itself is a small molecule rather than a peptide, in the context of longevity protocols it is administered as a supplement via oral precursors (Nicotinamide Mononucleotide [NMN] or Nicotinamide Riboside [NR]) or directly via intravenous (IV) or subcutaneous (SC) injection. NAD+ levels decline dramatically with age, contributing to mitochondrial dysfunction, reduced DNA repair capacity, and accelerated aging. The discovery that NAD+ activates sirtuins—a family of longevity-promoting enzymes—launched NAD+ restoration as a cornerstone of modern anti-aging medicine. Dr. David Sinclair's foundational work at Harvard demonstrated that NAD+ boosting extends lifespan in animal models and reverses multiple hallmarks of aging.
Mechanism of Action
NAD+ functions through several critical mechanisms. First, it serves as an electron acceptor in glycolysis and the citric acid cycle, directly enabling ATP production in mitochondria. Second, NAD+ is the substrate for NAD+-dependent sirtuins (SIRT1–7), a family of deacetylases and ADP-ribosyltransferases that regulate cellular stress responses, circadian rhythms, DNA repair, and mitochondrial function. When NAD+ levels are high, sirtuins are activated, triggering a cascade of longevity-promoting effects: enhanced DNA repair (SIRT1, SIRT6), improved mitochondrial biogenesis (SIRT3, SIRT4), and metabolic flexibility (SIRT1). Third, NAD+ is cleaved by PARPs (poly-ADP-ribose polymerases) during DNA damage response and by CD38 (an NAD+-consuming enzyme upregulated with age), linking NAD+ availability to genomic stability. Finally, NAD+ is a substrate for sirtuins' regulatory role in mTOR, AMPK, and autophagy, key drivers of cellular rejuvenation. In essence, NAD+ acts as a cellular sensor of energy status, triggering repair and renewal when energy is abundant.
Research & Studies
The seminal work by Yoshino J et al., Cell Metab. 2011 demonstrated that NMN (an NAD+ precursor) improves glucose tolerance and mitochondrial function in aged mice. Rajman L et al., Cell Metab. 2018 provided a comprehensive review of NAD+ biology and aging, highlighting NAD+ decline with age and the benefits of precursor supplementation. Cantó C & Auwerx J, Cell Metab. 2012 elucidated sirtuin-mediated longevity mechanisms downstream of NAD+. In humans, Gong B et al., Aging Cell. 2019 showed that NMN supplementation improves muscle insulin sensitivity and mitochondrial function in prediabetic women. Multiple Phase 2 clinical trials are underway examining NMN and NR supplementation for age-related metabolic decline, cognitive function, and cardiovascular health. Direct IV NAD+ infusions have shown acute improvements in fatigue and cognitive clarity in preliminary reports, though rigorous controlled trials are limited.
Longevity and Anti-Aging Effects
NAD+ restoration addresses multiple interconnected hallmarks of aging. By activating sirtuins, NAD+ enhances DNA repair capacity, protecting against genomic instability—a key driver of aging and cancer. Mitochondrial sirtuins (SIRT3, SIRT4, SIRT5) improve mitochondrial oxidative phosphorylation and reduce ROS (reactive oxygen species) production, reversing age-related mitochondrial decline. SIRT1 activation in the brain enhances neuroplasticity and protects against cognitive aging, while in muscle it improves metabolic flexibility and prevents age-related sarcopenia (muscle loss). By restoring NAD+-dependent circadian signaling, NAD+ resynchronizes biological clocks, improving metabolic health, immune function, and sleep quality. NAD+ restoration also enhances autophagy through AMPK activation downstream of SIRT1, promoting clearance of cellular damage. In preclinical models, NAD+ precursor supplementation extends lifespan, improves healthspan, and delays onset of age-related diseases. Human studies show improvements in metabolic parameters, physical endurance, and subjective energy levels, though effects are more modest than in rodent models.
Dosing & Protocol
Oral NAD+ precursor protocols differ between NMN and NR. NMN is typically dosed at 250–1000 mg daily (often 500 mg), taken with meals for optimal absorption. NR (Nicotinamide Riboside) is dosed at 250–1000 mg daily (often 500–750 mg). Standard practice is continuous daily supplementation rather than cycling. Direct IV NAD+ infusions are administered in clinical settings at doses of 500–1500 mg per infusion, typically once weekly or biweekly. IV administration provides higher bioavailability and immediate metabolic effects compared to oral precursors. SC NAD+ injections (less common) employ doses of 100–300 mg, 2–3 times weekly. Some practitioners use a loading phase of higher doses (1000 mg daily oral) for 30 days, followed by maintenance (250–500 mg daily). NAD+ levels peak 30–60 minutes after IV administration and 1–2 hours after oral intake. The half-life of orally administered precursors is estimated at 30–45 minutes, supporting daily dosing. Combining NAD+ with resveratrol (a sirtuin activator) is popular but may have diminishing returns due to pathway saturation.
Synergies
NAD+ is exceptional when combined with MOTS-c and SS-31 to form a comprehensive mitochondrial stack. MOTS-c activates AMPK, which consumes NAD+ to activate sirtuins, creating a direct metabolic feedback loop—NAD+ provides the substrate for SIRT1/3/5 activation, while AMPK activation (from MOTS-c) drives further NAD+ consumption and sirtuin engagement. SS-31 protects the inner mitochondrial membrane, preserving the organelles that NAD+ restoration aims to optimize. Epithalon adds circadian synchronization, enhancing the temporal coordination of NAD+-dependent repair processes. This four-peptide stack (NAD+ + MOTS-c + SS-31 + Epithalon) represents a comprehensive longevity protocol addressing energy production, genetic repair, mitochondrial health, and circadian alignment. NAD+ also synergizes with caloric restriction or intermittent fasting protocols, which naturally elevate NAD+ levels and activate sirtuins.
Receptor Overlaps & Avoidance
NAD+ and its precursors have minimal direct receptor overlap with other peptides. However, because NAD+ activates sirtuins and AMPK, concurrent use of strong AMPK activators (e.g., high-dose metformin) may create pathway saturation. Similarly, using multiple NAD+ precursors simultaneously (e.g., NMN + NR + direct IV NAD+) is redundant and may not provide additive benefit. Excessive nicotinamide or niacinamide supplementation (high-dose B vitamins) can interfere with NAD+ metabolism by competitive inhibition of NAD+ biosynthetic enzymes; maintain physiological B vitamin levels rather than supplementing above RDA. No significant interactions with growth hormone secretagogues, cognitive peptides, or immune-modulating peptides are documented. Individuals on SIRTuin inhibitors (not commonly used therapeutically) should avoid NAD+ restoration.
Safety Profile
NAD+ precursors (NMN, NR) demonstrate excellent safety in preclinical and early human trials. Oral NAD+ precursors at doses up to 1000–1500 mg daily show no serious adverse effects. Potential side effects are mild and transient, including nausea, headache, and flushing (particularly with IV NAD+), which typically resolve within hours. Some users report increased energy and wakefulness, particularly with IV NAD+, occasionally requiring afternoon dosing to avoid sleep disruption. Rarely, mild hepatic enzyme elevation has been observed with high-dose NR, though this is reversible and benign. Direct IV NAD+ infusions are safe when administered by trained clinicians with appropriate sterility; peripheral phlebitis is rare. Long-term safety data spans 5+ years in clinical practice, supporting safety of continuous use. NAD+ precursors are not recommended for pregnant or breastfeeding women due to lack of safety data. Individuals with history of gout (niacin increases uric acid) should use caution and monitor uric acid levels, though this concern is theoretical at standard anti-aging doses. No interactions with common medications are documented.